Das Kloster
Mürgstrasse 18
CH-6370 Stans - Switzerland
T +41 (0)840 200 010
F +41 (0)840 200 011
media@mondobiotech.com
Welcome to Mondobiotech’s Investor Relations. mondoBIOTECH holding AG (SIX Swiss Exchange ticker symbol: RARE), an independent, internet-based biotech research company, discovers drugs for patients suffering from rare and neglected diseases. Mondobiotech has built a continuously growing global community of biologists, biochemists, physicians, patients and patient advocacy organizations who share their passion and skills with Mondobiotech. Together with Mondobiotech, this community is searching for treatments for rare and neglected diseases.
Through our unique “Search & Match” engine and the collaboration with our worldwide community we have so far discovered more than 300 medicinal product candidates for further exploration in as many as possible of the 7000 rare diseases. Our products feature two major characteristics: they are biologically active peptides of human origin and have platform potentiality for at least 3 orphan indications.
Investor Relations Contacts
Maria Teresa D'Antonangelo Bühlmann, Investor & External Relations
mondoBIOTECH holding AG
Mürgstrasse 18
CH-6370 Stans
Switzerland
T. +41 (0)840 200 010
F. +41 (0)840 200 011
investor@mondobiotech.com
Stock Information
Company Presentation
Development Pipeline
Fact Sheet
Letter from the founders
- Mondobiotech
- Fast fact
- Overview
- Milestones
- Board of Directors
- Management
- Location
- Products
- Product Overview
- Types of products
- Pipeline
- Rare Diseases
- About Rare Diseases
- Patient and Families
- Rare Diseases List
- Media Archive
- Investor
- Financial Information
- Key Information
- Corporate Governance
- Appointments
- Partnership
- Pipeline
- Science
- Pipeline
- Product Overview
- Research Vision